Isolated left ventricular non-compaction controversies in diagnostic criteria, adverse outcomes and management

Paaladinesh Thavendiranathan1, Arun Dahiya, Dermot Phelan

  • 1Department of Cardiology, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH 44195, USA.

Insights

Isolated left ventricular non-compaction (LVNC) is a heart muscle disorder. This review clarifies diagnostic criteria and management strategies for LVNC, addressing current controversies in cardiovascular imaging.

Area of Science:

  • Cardiology
  • Medical Imaging

Background:

  • Isolated left ventricular non-compaction (LVNC) is a morphological abnormality characterized by excessive left ventricular trabeculation.
  • LVNC is frequently associated with ventricular dysfunction, arrhythmias, and cardioembolic events.
  • Increased diagnosis of LVNC is driven by advances in cardiovascular imaging technology.

Purpose of the Study:

  • To review current controversies in the clinical diagnosis of LVNC.
  • To provide an evidence-based overview of diagnostic criteria for LVNC.
  • To suggest a management approach for patients with LVNC.

Main Methods:

  • Literature review of recent studies on LVNC diagnosis and management.
  • Analysis of current controversies in clinical diagnosis.
  • Synthesis of data to propose a management strategy.

Main Results:

  • Diagnosis of LVNC is increasing due to improved imaging availability.
  • Diagnostic criteria and management strategies for LVNC remain subjects of debate.
  • Recent studies highlight the utility of novel diagnostic methods and adverse event incidence.

Conclusions:

  • Standardized, evidence-based imaging diagnostic criteria for LVNC are needed.
  • A clear management approach is essential for LVNC.
  • Further research is required to resolve diagnostic and therapeutic controversies.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...